Doç. Dr. Erkan Cüre

• Pneumonia, Viral 15 publications
  Source: OpenAlex / PubMed MeSHView publications
• Coronavirus Infections 15 publications
• COVID-19 7 publications
• Reperfusion Injury 6 publications
• Gilbert Disease 5 publications
• Spondylitis, Ankylosing 5 publications
• Behcet Syndrome 5 publications
• Arthritis, Rheumatoid 5 publications
• Diabetes Mellitus 3 publications
• Diabetes Mellitus, Type 2 2 publications
• Lupus Erythematosus, Systemic 2 publications
• Restless Legs Syndrome 2 publications
• Sleep Wake Disorders 2 publications
• Fibromyalgia 2 publications
• Respiratory Distress Syndrome 2 publications
• ST Elevation Myocardial Infarction 2 publications
• Thrombosis 2 publications
• Arthritis, Psoriatic 2 publications
• Coronary Artery Disease 2 publications
• Cardiovascular Diseases 2 publications
• Familial Mediterranean Fever 2 publications
• Arrhythmias, Cardiac 2 publications
• Hypoglycemia 2 publications

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.

Experience

• 1999to 2000: General Practitioner, Umutlu Primary Health Care Centre, Akdağmadeni, Yozgatmedicalpark.com.tr
• 2000to 2002: Resident in Neurosurgery, Ondokuz Mayıs University Faculty of Medicinemedicalpark.com.tr
• 2002to 2008: Resident in Internal Medicine, Süleyman Demirel University Faculty of Medicinemedicalpark.com.tr
• 2008to 2009: Specialist Physician, Internal Medicine, Safranbolu State Hospitalmedicalpark.com.tr
• 2009to 2010: Medical Officer (Second Lieutenant, reserve), Infirmary of the Third Army Command, Erzincanmedicalpark.com.tr
• 2010to 2012: Specialist Physician, Internal Medicine, Safranbolu State Hospitalmedicalpark.com.tr
• 2012to 2016: Faculty Member (Öğretim Üyesi), Internal Medicine, RTEÜ Faculty of Medicinemedicalpark.com.tr
• 2017to 2018: Çamlıca Erdem Hastanesi (private hospital)medicalpark.com.tr
• 2019to 2021: Ota&Jinemed Hastanesi (private hospital)medicalpark.com.tr
• 2021to 2021: Ethica Hastanesi (private hospital)medicalpark.com.tr
• 2021to 2022: Bağcılar Medilife Hastanesi (private hospital)medicalpark.com.tr
• 2022to 2024: Beylikdüzü Medilife Hastanesi (private hospital)medicalpark.com.tr
• 2024Bahçelievler Medicana Hastanesi (private hospital) – presentmedicalpark.com.tr
• 2024İstinye University Medical Park Gaziosmanpaşa Hospitalmedicalpark.com.tr

Education

• Education1999 Ondokuz Mayıs University Faculty of Medicinemedicalpark.com.tr
• Education2007 Süleyman Demirel University, Internal Medicinemedicalpark.com.tr

• SpecialtyInternal Medicinemedicalpark.com.trFrom source
• Department name at the sourceİç Hastalıkları (Dahiliye)medicalpark.com.trFrom source
• Institutionİstinye Üniversitesi Medical Park Gaziosmanpaşamedicalpark.com.trFrom source
• Area of workPneumonia, ViralExtracted from 15 publications · Model version —From source
• Publications154 publicationsORCIDFrom source
• ORCID0000-0001-7807-135XORCIDFrom source
• Last synchronised4 November 2026 20:32https://www.medicalpark.com.tr/hekimler/erkan-curemedicalpark.com.tr

1. Syndecan-1 as a Biomarker for Cardiovascular Risk in Patients with Behçet’s Disease

   Archives of Rheumatology, 2025

   DOI 10.5152/archrheumatol.2025.11178 PMID 41578772 Open-access full textSource: ORCID

2. Emerging risks of lipid-lowering therapy and low LDL levels: implications for eye, brain, and new-onset diabetes

   Lipids in Health and Disease, 2025

   DOI 10.1186/s12944-025-02606-6 PMID 40399888 6 citations (Europe PMC) Open-access full textSource: ORCID

3. Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome

   Archives of Rheumatology, 2024

   DOI 10.46497/archrheumatol.2024.10462 PMID 39507838 2 citations (Europe PMC) Open-access full textSource: ORCID

4. Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?

   Current Pharmaceutical Design, 2024

   DOI 10.2174/0113816128300162240322075423 PMID 38566383 Source: ORCID

5. Severe acute respiratory syndrome coronavirus 2 may cause liver injury via Na+/H+ exchanger.

   World journal of virology, 2023

   DOI 10.5501/wjv.v12.i1.12 PMID 36743661 Open-access full textSource: ORCID

6. Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus

   Journal of Endocrinological Investigation, 2022

   DOI 10.1007/s40618-022-01951-y PMID 36318448 4 citations (Europe PMC) Open-access full textSource: ORCID

7. Prolonged NHE Activation may be Both Cause and Outcome of Cytokine Release Syndrome in COVID-19

   Current Pharmaceutical Design, 2022

   DOI 10.2174/1381612828666220713121741 PMID 35838211 5 citations (Europe PMC) Source: ORCID

8. Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease

   Clinical and Experimental Hypertension, 2022

   DOI 10.1080/10641963.2022.2071921 PMID 35502687 2 citations (Europe PMC) Source: ORCID

9. The effects of TNF-α inhibitors on carbon tetrachloride-induced nephrotoxicity

   Clinical and Experimental Hypertension, 2021

   DOI 10.1080/10641963.2021.2018600 PMID 34964416 7 citations (Europe PMC) Source: ORCID

10. Effects of the Na+/H+ Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease

    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2021

    DOI 10.1155/2021/4754440 PMID 34285709 8 citations (Europe PMC) Open-access full textSource: ORCID